EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Intravascular Lymphoma: A Unique Pattern Underlying a Protean Disease

Mario Della Mura, Joana Sorino iD, Filippo Emanuele Angiuli, Gerardo Cazzato iD, Francesco Gaudio iD, Giuseppe Ingravallo iD

Cancers · 15.07.2025 · 17 (14) · 2355

DOI: 10.3390/cancers17142355 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 15.07.2025. Verfasst von Mario Della Mura und 5 weiteren Autor:innen. Beteiligte Einrichtung: Section of Molecular Pathology, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari "Aldo Moro", 70124 …. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intravascular lymphoma (IVL) is a rare, aggressive subtype of non-Hodgkin lymphoma (NHL) characterized by the selective proliferation of neoplastic lymphoid cells within small and medium-sized blood vessels, most frequently of B-cell origin (IVLBCL). Its protean clinical presentation, lack of pathognomonic findings, and absence of tumor masses or lymphadenopathies often lead to diagnostic delays and poor outcomes. IVLBCL can manifest in classic, hemophagocytic syndrome-associated (HPS), or cutaneous variants, with extremely variable organ involvement including the central nervous system (CNS), skin, lungs, and endocrine system. Diagnosis requires histopathologic identification of neoplastic intravascular lymphoid cells via targeted or random tissue biopsies. Tumor cells are highly atypical and display a non-GCB B-cell phenotype, often expressing CD20, MUM1, BCL2, and MYC; molecularly, they frequently harbor mutations in MYD88 and CD79B, defining a molecular profile shared with ABC-type DLBCL of immune-privileged sites. Therapeutic approaches are based on rituximab-containing chemotherapy regimens (R-CHOP), often supplemented with CNS-directed therapy due to the disease’s marked neurotropism. Emerging strategies include autologous stem cell transplantation (ASCT) and novel immunotherapeutic approaches, potentially exploiting the frequent expression of PD-L1 by tumor cells. A distinct but related entity, intravascular NK/T-cell lymphoma (IVNKTCL), is an exceedingly rare EBV-associated lymphoma, showing unique own histologic, immunophenotypic, and molecular features and an even poorer outcome. This review provides a comprehensive overview of the current understandings about clinicopathological, molecular, and therapeutic landscape of IVL, emphasizing the need for increased clinical awareness, standardized diagnostic protocols, and individualized treatment strategies for this aggressive yet intriguing malignancy.

Schlagwörter

Stichwörter der Autor:innen

B-cell lymphomaNK/T-cell lymphomaintravascular lymphomaintravascular lymphomatosisnon-Hodgkin lymphoma

Autor:innen und Institutionen

  • Section of Molecular Pathology, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari "Aldo Moro", 70124 Bari, Italy.
  • Unit of Haematology, Department of Medicine and Surgeon, F. Miulli University Hospital, LUM University, Casamassima, 70010 Bari, Italy.

ORCID-Profile: Joana Sorino, Gerardo Cazzato, Francesco Gaudio, Giuseppe Ingravallo

Zitieren

APA

Della Mura, M., Sorino, J., Angiuli, F. E., Cazzato, G., Gaudio, F., & Ingravallo, G. (2025). Intravascular Lymphoma: A Unique Pattern Underlying a Protean Disease. Cancers, 17(14), 2355. https://doi.org/10.3390/cancers17142355

Vancouver

Della Mura M, Sorino J, Angiuli FE, Cazzato G, Gaudio F, Ingravallo G. Intravascular Lymphoma: A Unique Pattern Underlying a Protean Disease. Cancers. 2025;17(14):2355. doi:10.3390/cancers17142355

BibTeX
@article{DellaMura2025,
  author = {Della Mura, Mario and Sorino, Joana and Angiuli, Filippo Emanuele and Cazzato, Gerardo and Gaudio, Francesco and Ingravallo, Giuseppe},
  title = {Intravascular Lymphoma: A Unique Pattern Underlying a Protean Disease},
  journal = {Cancers},
  year = {2025},
  volume = {17},
  number = {14},
  pages = {2355},
  doi = {10.3390/cancers17142355}
}
Kostenlos starten →